BioMarin Pharmaceutical (BMRN) Surpasses Q4 Earnings and Revenue Estimates

BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of$ 0.73 per share. This compares to earnings of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 26.03%. A quarter ago, it was expected that this rare disease biopharmaceutical would post earnings of$ 0.78 per share when it actually produced earnings of $0.91, delivering a surprise of 16.67%.Over the l ...